Clinical Trial Update: Clinical Investigation of the Bacterially-Derived Healon5 Ophthalmic Viscosurgical Device (OVD) [NA]

View source ↗

Summary

Clinical investigation of the bacterially-derived Healon5 ophthalmic viscosurgical device for cataract surgery has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Healon5 (ophthalmic viscosurgical device (hyaluronate-based; bacterially-derived))

Snippet

Sponsor: Abbott Medical Optics | Conditions: Cataract | NA | Status: COMPLETED | Results posted: 2018-05-24